DMI Biotech

We are honoured to collaborate with UMPSA-FIST since 2022. Our journey continue with MOA exhange on 10/042025 with UMPSA-FIST in phase 2 project in which this collaboration focusing on large scale Cordyceps Sinensis cultivation and its medicinal analysis study. Being one of 33 companies selected under the IMaP program sponsor by Kementerian Pengajian Tinggi Malaysia, this enhance our confident in our technology in which will optimize further our relevant products efficacy and quality.

Thank you UMPSA and all the customers who putting the trust in us. We are committed bring DMI Biotech towards better innovation and impactful breakthroughs technology.

Today our team visited ABRC (Analytical Biochemistry Research Center), USM to withness the largest Bioreactor in SEA and discuss future collaboration with USM and Dr Tan on our Cordyceps cultivation enhancement and active components further activation.